论文部分内容阅读
随着成分输血的广泛开展,血小板输血已成为重要的临床支持治疗,其输用量逐年增加,适用于治疗血小板减少或血小板功能缺陷患者的出血[1,2]。血液病本身和治疗过程中
With the extensive development of transfusion of blood components, platelet transfusion has become an important clinical supportive treatment. The transfusion dose is increasing year by year and is suitable for the treatment of patients with thrombocytopenia or platelet dysfunction [1, 2]. Blood disease itself and the course of treatment